πŸ‡ΊπŸ‡Έ FDA
Patent

US 8729119

Serotonin reuptake inhibitors

granted A61PA61P1/00A61P1/04

Quick answer

US patent 8729119 (Serotonin reuptake inhibitors) held by Theravance, Inc. expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/00, A61P19/02